Skip to main content
OpenTrials
Completed

NCT Number: NCT01521650

Probiotics Against Pathogenic Bacteria in Connection With Anaesthesia

Longer surgical procedures require intubation and there is a potential risk of contaminating the lower airways with pathogenic bacteria from the mouth and oropharynx.

Healthy people seldom have pathogenic bacteria originating from the gastro-intestinal canal but those do occur among patients, both in those not so sick and patients with more severe problems.

For ICU patients we have seen a reduction of emerging enteric bacteria in patients given oral care with probiotics and this is a pilot study to explore the possibility of the same kind of positive effects in patients due for longer (more than 4 hours of anesthesia) procedures.

Randomisation

* No prophylaxis * Preparation with a probiotic suspension before intubation.

Cultures

* oropharynx

* before treatment * after intubation * before extubation * day 1 postoperatively * tracheal secretions

* after intubation * before extubation

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Lund University Hospital

Lund, SE-22185, Sweden

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients
  • Planned interventions
  • Anaesthesia > 4 hours and requiring intubation

Exclusion criteria

  • Ulcers in the mouth, oropharynx, oesophagus and stomach
  • Current infections in the airways
  • Known immuno deficiences
  • Emergency cases

Treatment and study plan

Probiotics

Dietary Supplement

Patients will gurgle and swallow a mixture of probiotic bacteria

Other names: Lactobacillus plantarum 299, Lactobacillus plantarum 299v

Primary outcomes

  1. Differences in pathogenic bacteria in the oropharynx and lower airways

    Time frame: During hospitalization, up to 4 weeks

    Emerging and resident bacteria will be compared for the cultures taken in the oropharynx and from tracheal secretions in conection with anaestesia and a surgical intervention

Secondary outcomes

  1. White blood cells

    Time frame: During hospitalization, up to 4 weeks

    WBC taken pre-op and days 1,2,3 post-op

  2. CRP

    Time frame: During hospitalization, up to 4 weeks

    CRP taken pre-op and days 1,2,3 post-op

  3. Pneumonia

    Time frame: Up till 7 days postoperatively

    X-ray verified infiltrations in combination with expectorates

  4. Length of hospital stay

    Time frame: time to discharged from hospital or patients death

    Comparison of length of stay between the intervention group and the control group

Sponsors and collaborators

Lead sponsor

Region Skane

Other

Collaborators

  • Lund University

Registry information

Official study title

Probiotics for Reduction of Colonisation With Pathogenic Bacteria in the Oropharynx in Connection With Anaesthesia

Important dates

Study start
2012
Primary completion
2019
Study completion
2020
First posted
Jan 31, 2012
Registry last updated
Mar 10, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.